Evidence map›Paper›PMID 42652901›Full record

ArticleJournal of clinical medicine2026

Course of Testosterone Levels and Potential Biochemical Biomarkers of Androgenization with a Conservative Protocol of Androgen Hormone Therapy in Transgender Males.

Guillermo Velasco de Cos, María Teresa García Unzueta, Ana Moyano Martínez, Pedro Muñoz Cacho, Aurelia Villar Bonet, Armando Raul Guerra Ruiz, Bernardo A Lavin-Gómez, Maialen Ormazabal Monterrubio, Luis Alberto Vázquez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Guillermo Velasco de CosClinical Laboratory, Valladolid University Hospital, 47003 Valladolid, Spain.ORCID 0000-0002-7260-3789
María Teresa García UnzuetaBiochemistry and Clinical Analysis Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.ORCID 0000-0003-2531-3284
Ana Moyano MartínezClinical Laboratory, Salamanca University Healthcare Complex, 37007 Salamanca, Spain.
Pedro Muñoz CachoDepartment of Medicina Familiar y Comunitaria (IDIVAL), 39008 Santander, Spain.ORCID 0000-0002-1387-2655
Aurelia Villar BonetEndocrinology and Nutrition, 39008 Santander, Spain.
Armando Raul Guerra RuizBiochemistry and Clinical Analysis Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.ORCID 0000-0001-8896-8611
Bernardo A Lavin-GómezBiochemistry and Clinical Analysis Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.ORCID 0000-0001-7279-7643
Maialen Ormazabal MonterrubioBiochemistry and Clinical Analysis Department, Marqués de Valdecilla University Hospital, 39008 Santander, Spain.
Luis Alberto VázquezFaculty of Medicine, University of Cantabria, 39005 Santander, Spain.ORCID 0000-0003-4929-4479

Funding

Instituto de Investigación Marqués de Valdecilla Mentoring MTVAL21/01
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

gender-affirming hormone therapyhematocritlipidsprostate-specific antigensafetysex steroidstestosterone therapytransgender males

Identifiers

PMID42652901
PMCPMC13514267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.